Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), currently valued at $3.97 billion, has positioned itself as a key player in the ...

Xencor Inc . (NASDAQ:XNCR), a biopharmaceutical company specializing in innovative therapies for immunology and oncology, finds itself at a critical juncture as it advances its pipeline and expands ...

Pure Hydrogen has started 2025 with a bang, securing a purchase order from global logistics provider TOLL Transport for the ...

The Citizens Utility Board and other advocates hope their "unprecedented" ad buy will help slash spending on the utility's ...

The Citizens Utility Board and other advocates hope their "unprecedented" ad buy will help slash spending on the utility's ...

Maryland children are raising their voices in a song that raises awareness for gun trafficking and the violence associated ...

MSD Partners wants to build a condominium at the historic Boca Raton resort.

After years of shrinking the prominence of commercial real estate in its portfolio, M&T Bank has hit its target and begun to ...

Annemarie Hanekamp has overseen some of the most transformative changes in oncology over her years in Big Pharma. Now, she ...

Joseph Pantginis, an analyst from H.C. Wainwright, reiterated the Buy rating on Rigel (RIGL – Research Report). The associated price target ...

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced its preliminary* fourth ...

Enbridge’s Line 5 pipeline carries 540,000 barrels of light crude oil, light synthetic crude and natural gas liquids a day ...